March 2018

Sekisui XenoTech Named Best In Vitro Drug Metabolism Studies Provider 2018

Author:  Michael Millhollen
Posted:  27 March 2018

Following our nomination in late 2017, Sekisui XenoTech has been named the Best In Vitro Drug Metabolism Studies Provider in the 2018 Biotechnology Awards. From the award announcement:

Following on from last years’ success, the 2018 Biotechnology Awards once again recognise and spotlight the key players and companies within this ever-evolving and ground-breaking industry, and will create a true representation of the very best that the industry has to offer.

The 2018 Biotechnology Awards are our way of spreading the word about this truly captivating and vital industry, whilst acknowledging and commending the clinicians, chemists, researchers, engineers, and MDs who create the way for others to follow, paving the way for a better future.

Commenting on the success of these awards, Kaven Cooper, Awards Coordinator was eager to highlight the success of these deserving winners: “As the biotechnology movement continues to gain momentum, we honour those who develop and form the healthcare world for years to come. They have achieved phenomenal success over the past twelve months, and I wish them all the best for the years to come.”

Learn more about Sekisui XenoTech's products and services.

About the 2018 Biotechnology Awards
The awards are given solely on merit and are awarded to commend those most deserving for their ingenuity and hard work, distinguishing them from their competitors and proving them worthy of recognition. A thorough research process is employed to ensure an accurate representation of the best that this market has to offer.

Blog post currently doesn't have any comments.
Give Feedback